コンテンツへスキップ
Merck

Central role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development.

Oncotarget (2017-11-02)
Pin Liu, Diego F Calvisi, Andras Kiss, Antonio Cigliano, Zsuzsa Schaff, Li Che, Silvia Ribback, Frank Dombrowski, Dongchi Zhao, Xin Chen
要旨

Hepatoblastoma (HB) is the most common type of liver malignancy in children. Recent studies suggest that activation of Yes-associated protein (YAP) is a major molecular event in HB development, as activated YAP synergizes with mutant β-catenin to promote HB formation in mice (YAP/β-catenin). However, how YAP regulates HB development remains poorly defined. Similarly, de-regulation of mammalian target of rapamycin complex 1 (mTORC1) signaling has been implicated in multiple tumor types, but its functional role in HB development is scarcely understood. In the present study, we found that mTORC1 is activated in human HB cells and YAP/β-catenin-induced mouse HB tumor tissues. mTOR inhibitor MLN0128 significantly inhibits human HB cell growth

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
モノクロナール抗β-アクチン マウス宿主抗体, clone AC-15, ascites fluid
Sigma-Aldrich
抗グリセルアルデヒド-3-リン酸デヒドロゲナーゼ抗体、クローン6C5, clone 6C5, Chemicon®, from mouse
Sigma-Aldrich
3-(ビフェニル-4-イル)-5-(4-tert-ブチルフェニル)-4-フェニル-4H-1,2,4-トリアゾール, 97%
Sigma-Aldrich
Anti-SLC38A1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution